Brief: Xeris Enters Into An Exclusive Worldwide Collaboration And License Agreement With Beta Bionics
May 6 (Reuters) - Xeris Biopharma Holdings Inc XERS.O :
* XERIS ENTERS INTO AN EXCLUSIVE WORLDWIDE COLLABORATION AND
LICENSE AGREEMENT WITH BETA BIONICS
* XERIS BIOPHARMA: POTENTIAL TO GET DEVELOPMENT PAYMENTS,
PLUS LOW
DOUBLE-DIGIT ROYALTIES BASED ON FUTURE SALES OF XERIS GLUCAGON
FOR PUMPS, PUMP SYSTEMS
Source text for Eikon: ID:nBw91YHhxa
Further company coverage: XERS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest